ヤクアミドBの標的識別とミトコンドリアFoF1-ATP合成に対する2つの異なる活動
Kai Kitamura1, Hiroaki Itoh1, Kaori Sakurai2
1Graduate School of Pharmaceutical Sciences , The University of Tokyo , 7-3-1 Hongo , Bunkyo-ku, Tokyo 113-0033 , Japan.
Journal of the American Chemical Society
|August 30, 2018
まとめ
ヤクアミドBは新しいペプチドで がん細胞のミトコンドリアを 選択的に攻撃します ATPの合成を阻害し,ATPの水解を強化することで細胞のエネルギーを破壊し,抗癌薬の開発の新しい戦略を提供します.
科学分野:
- 生物化学
- 分子生物学
- 薬剤化学
背景:
- ヤクアミドB (1b) は,潜在的な抗がん性を持つユニークなテトラデカペプチドです.
- 独特の成長阻害性プロファイルは,既存の薬と比較して新しい作用メカニズムを示唆しています.
研究 の 目的:
- ヤクアミドBを合成する
- 細胞の標的と作用の仕方を 解明する
- 新しい抗がん剤の開発のための構造的基盤を確立する.
主な方法:
- ヤクアミドB誘導体 (光およびバイオチニル化) の総合成
- 制御実験のための非自然なエナティオメアの合成.
- 光探知器を用いた細胞下局所化研究.
- 標的タンパク質を特定するためのプルダウンアッセイ
- 酵素活性を評価する生化学的測定法
主要な成果:
- ヤクアミドBは,乳がん細胞のミトコンドリアに選択的に蓄積する.
- F0F1-ATP合成酵素が主な標的タンパク質として特定された.
- ヤクアミドBはミトコンドリアのATP生成を抑制し,ATPの水解を強める.
- 不自然なエナチオメアは弱く抑制され,ステレオ特異性を示した.
結論:
- ヤクアミドBは,細胞のATPを枯渇させることで,癌細胞の成長停止を誘導する.
- このメカニズムは,ミトコンドリアのF0F1- ATP合成酵素に対する二重作用を伴う.
- この発見は,ヤクアミドBの独特の作用を基に,新しい抗がん治療法を設計するための基礎となる.
さらに関連する動画
関連する概念動画
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:28ATP and Macromolecule Synthesis
Biological macromolecules are organic compounds, predominantly composed of carbon atoms. The carbon atoms are covalently bonded with hydrogen, oxygen, nitrogen, and other minor elements. There are four major biological macromolecule classes: carbohydrates, lipids, proteins, and nucleic acids.
Most macromolecules are composed of single subunits, or building blocks, called monomers. The monomers combine with each other using covalent bonds to form larger molecules known as polymers.
Conversion of...
Most macromolecules are composed of single subunits, or building blocks, called monomers. The monomers combine with each other using covalent bonds to form larger molecules known as polymers.
Conversion of...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...